Liver Resection after Irinotecan, 5-Fluorouracil, and Folinic Acid for Patients with Unresectable Colorectal Liver Metastases: A Multicenter Phase II Study by the Cancer Therapeutic Research Group
Wing Ming Ho(Chinese University of Hong Kong), Anthony T.�C. Chan(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Ann D. King(College of American Pathologists), Yuk Wong(Prince of Wales Hospital), Winnie Yeo(Chinese University of Hong Kong), Brigette Ma(Chinese University of Hong Kong), C. K. Leow(National University Hospital), Robert Lim(Ontario Institute for Cancer Research), Tony Mok(Chinese University of Hong Kong), Jane Koh(Chinese University of Hong Kong)
Cited by 56
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k